美國
US 12,702,687 B2
Pharmaceutical composition for preventing or treating cholestatic liver injury comprising Leuconostoc citreum strain as active ingredient
US 12,702,687 B2 是美國專利商標局（USPTO）的核准專利，日期 2026-08-11。申請人：LISCure Bio Inc.。PDF 可在本頁下載，未登入每天最多 5 篇。
- 申請人
- LISCure Bio Inc.
- 發明人
- Hwa Sup CHIN
- 公開日
- 2026-08-11
- 申請日
- 2023-08-07
- 文件種類
- B2 核准公告
- 也寫作
- US 12,702,687 B2 · US12702687 · 12702687
摘要
The present invention relates to a composition comprising a Leuconostoc citreum strain or its culture as an active ingredient for preventing, improving or treating cholestatic liver injury, specifically primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC). According to the present invention, since the composition exhibits excellent preventive and therapeutic effects on various cholestatic liver injuries, the composition can be usefully used as a composition for the treatment, prevention, improvement, or the like of cholestatic liver injury in humans or animals.
這裡只列摘要開頭，完整內容在 PDF 裡。
不用登入，每天可下載 5 篇（今天還剩 5 篇）。批次下載與 OA 引證整理需免費註冊。
專利局網站： 美國專利商標局（USPTO）